Argan Gemma CEO sells shares after option exercises
ARGAN INC executive Charles Edwin Collins IV, CEO of Gemma, reported option exercises and share sales in April 2026.
Rhea-AI Filing Summary
ARGAN INC executive Charles Edwin Collins IV, CEO of Gemma, reported option exercises and share sales in April 2026. He exercised stock options to acquire a total of 13,568 shares of common stock at exercise prices ranging from $33.81 to $148.72 per share.
On April 20, 2026, he exercised an option for 2,500 shares at $39.47 per share and sold 2,500 shares at $610 per share. On April 21, 2026, he exercised additional options totaling 11,068 shares and sold 11,068 shares at an average price of $621.61 per share. Following these transactions, he directly holds 30,320 shares of ARGAN common stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Option to Purchase Common Stock | 5,000 | $36.78 | $184K |
| Exercise | Option to Purchase Common Stock | 5,235 | $33.81 | $177K |
| Exercise | Option to Purchase Common Stock | 500 | $61.22 | $31K |
| Exercise | Option to Purchase Common Stock | 333 | $148.72 | $50K |
| Exercise | Common Stock | 5,000 | $36.78 | $184K |
| Exercise | Common Stock | 5,235 | $33.81 | $177K |
| Exercise | Common Stock | 500 | $61.22 | $31K |
| Exercise | Common Stock | 333 | $148.72 | $50K |
| Sale | Common Stock | 11,068 | $621.61 | $6.88M |
| Exercise | Option to Purchase Common Stock | 2,500 | $39.47 | $99K |
| Exercise | Common Stock | 2,500 | $39.47 | $99K |
| Sale | Common Stock | 2,500 | $610.00 | $1.52M |
Footnotes (7)
- F1. On April 20, 2026, the Reporting Person exercised his stock option awarded on April 17, 2023 to purchase 2,500 shares of the Issuer's common stock at a price of $39.47 per share.
- F2. On April 20, 2026, the Reporting Person sold 2,500 shares of the Issuer's common stock on the open market at a price of $610 per share.
- F3. On April 21, 2026, the Reporting Person exercised his stock option awarded on April 18, 2022 to purchase 5,000 shares of the Issuer's common stock at a price of $36.78 per share.
- F4. On April 21, 2026, the Reporting Person exercised the remaining portion of his stock option awarded on April 16, 2020 to purchase 5,235 shares of the Issuer's common stock at a price of $33.81 per share.
- F5. On April 21, 2026, the Reporting Person exercised a portion of his stock option awarded on April 16, 2024 to purchase 500 shares of the Issuer's common stock at a price of $61.22 per share.
- F6. On April 21, 2026, the Reporting Person exercised a portion of his stock option awarded on April 10, 2025 to purchase 333 shares of the Issuer's common stock at a price of $148.72 per share.
- F7. On April 21, 2026, the Reporting Person sold 11,068 shares of the Issuer's common stock on the open market at an average price of $621.61 per share.
Key Figures
Key Terms
open-market sale financial
stock option financial
derivative security financial
Option to Purchase Common Stock financial
exercise price financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did AGX executive Charles Edwin Collins IV report?
What stock options did Collins exercise in this Form 4 for AGX?
What is the overall pattern of Collins’ April 2026 AGX trades?
AI-generated analysis. How Rhea-AI works. Not financial advice.